BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/6/2019 5:44:00 PM | Browse: 1010 | Download: 2170
 |
Received |
|
2019-03-04 06:11 |
|
Peer-Review Started |
|
2019-03-04 08:03 |
|
To Make the First Decision |
|
2019-04-02 02:57 |
|
Return for Revision |
|
2019-04-03 00:32 |
|
Revised |
|
2019-04-14 15:38 |
|
Second Decision |
|
2019-04-18 10:09 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-04-19 01:45 |
|
Articles in Press |
|
2019-04-19 01:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-04-30 19:25 |
|
Typeset the Manuscript |
|
2019-06-05 09:53 |
|
Publish the Manuscript Online |
|
2019-06-06 17:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yi-Chun Chen, Chung-Yi Li, Shiang-Jiun Tsai and Yen-Chun Chen |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Dalin Tzu Chi Hospital |
DTCRD 104-I-16 |
|
| Corresponding Author |
Yi-Chun Chen, MD, Assistant Professor, Doctor, Doctor, Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No. 2, Minsheng Rd., Dalin Township, Chiayi County 622, Taiwan. chenyichun0320@yahoo.com.tw |
| Key Words |
Hepatitis C virus; Chronic kidney disease; End-stage renal disease; Anti-hepatitis C virus therapy; Cohort study |
| Core Tip |
This large nationwide retrospective cohort study used propensity score-matched and competing risk analyses to evaluate the long-term hard endpoints of hepatitis C virus (HCV) infection and anti-HCV therapy, especially interferon-based therapy, in chronic kidney disease (CKD) patients. We found that untreated HCV infection in CKD was associated with increased risks of end-stage renal disease and mortality. On the contrary, adequate anti-HCV therapy in CKD patients improves long-term renal and patient survivals. |
| Publish Date |
2019-06-06 17:44 |
| Citation |
Chen YC, Li CY, Tsai SJ, Chen YC. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals. World J Clin Cases 2019; 7(11): 1270-1281 |
| URL |
URL: https://www.wjgnet.com/2307-8960/full/v7/i11/1270.htm |
| DOI |
DOI: https://dx.doi.org/10.12998/wjcc.v7.i11.1270 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
